Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.340
-0.010 (-0.74%)
Jan 2, 2026, 11:23 AM EST - Market open
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $86.77 million as of January 2, 2026. Its market cap has decreased by -60.60% in one year.
Market Cap
86.77M
Enterprise Value
-152.83M
1-Year Change
-60.60%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $86.77M, a decrease of -85.23%. That is a compound annual growth rate of -28.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.78B |
| Johnson & Johnson | 497.76B |
| AbbVie | 405.60B |
| UnitedHealth Group | 301.35B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 262.40B |
| Novo Nordisk | 227.63B |